تحميل...
Mechanisms of immune evasion and current status of checkpoint inhibitors in non‐small cell lung cancer
In the past several years, immunotherapy has emerged as a viable treatment option for patients with advanced non‐small cell lung cancer (NSCLC) without actionable driver mutations that have progressed on standard chemotherapy. We are also beginning to understand the methods of immune evasion employe...
محفوظ في:
| الحاوية / القاعدة: | Cancer Med |
|---|---|
| المؤلفون الرئيسيون: | , , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
John Wiley and Sons Inc.
2016
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5055165/ https://ncbi.nlm.nih.gov/pubmed/27416962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.819 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|